IBSP and Hand-foot syndrome: SPAS patients showed a significantly earlier decline (P < 0.05, Cox proportional hazard models correcting for age at first injection) as at least 50% self‐perceived symptom reduction was already reached by 7 years of treatment in 60% of the patients compared to 16 years for CD, BSP, and HFS patients (Fig. 2).